Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management
He will continue to lead business in LATAM and Asia regions in this new role
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The companies plan to use the proceeds to retire debt and expand operations
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
Prior to IHH, Anurag held senior leadership roles in Fortis Healthcare and Manipal Health Enterprises.
Subscribe To Our Newsletter & Stay Updated
